Acadia Healthcare Company, Inc. $ACHC Shares Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 27.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 558,486 shares of the company’s stock after acquiring an additional 120,197 shares during the period. Principal Financial Group Inc.’s holdings in Acadia Healthcare were worth $13,063,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN boosted its stake in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd acquired a new position in shares of Acadia Healthcare in the fourth quarter valued at approximately $52,000. GAMMA Investing LLC grew its holdings in shares of Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after purchasing an additional 2,698 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its stake in Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after buying an additional 5,203 shares during the period.

Analyst Ratings Changes

ACHC has been the subject of a number of recent research reports. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. TD Cowen upped their price target on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. UBS Group lifted their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Royal Bank Of Canada boosted their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Finally, Cantor Fitzgerald lifted their price target on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $28.69.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $34.51 on Friday. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $35.83. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The firm has a market capitalization of $3.17 billion, a PE ratio of -2.82, a price-to-earnings-growth ratio of 11.34 and a beta of 0.64. The business’s fifty day moving average price is $27.64 and its 200 day moving average price is $23.18.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. During the same period in the previous year, the business earned $0.40 EPS. Acadia Healthcare’s revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.